A* gradient

Biomarker

1 paper3 findings

  • Humans1

Associations

3

Wrinkle formation

upin humans1

1 study
  1. A* gradient predicts wrinkle formation in humans.

    “the 10-year longitudinal study demonstrated that the a* gradient was associated with current and future skin ageing-related attributes, such as increased skin texture and wrinkle formation.”

    Humansskin10 yearsfemales

    Skin inflammatory signatures, as measured by disordered spatial redness patterns, predict current and future skin ageing attributes

    Experimental dermatologyAug 1, 2024

Cellular senescence

upin humans1

1 study
  1. A* gradient is associated with cellular senescence in humans.

    “Transcriptome analysis revealed upregulation of genes related to acute inflammation, chronic inflammation, cellular senescence, and angiogenesis in subjects with higher a* gradients.”

    Humansskinfemales

    Skin inflammatory signatures, as measured by disordered spatial redness patterns, predict current and future skin ageing attributes

    Experimental dermatologyAug 1, 2024

More on Cellular senescence

IL-8

upin humans1

1 study
  1. A* gradient is associated with IL-8 in humans.

    “A significant correlation was observed between the a* gradient and the levels of inflammatory cytokines (IL-1Ra/IL-1α and IL-8).”

    Humansskinfemales

    Skin inflammatory signatures, as measured by disordered spatial redness patterns, predict current and future skin ageing attributes

    Experimental dermatologyAug 1, 2024

More on IL-8

Latest

Nov 2025: 30Dec 2025: 39Jan 2026: 34Feb 2026: 10Mar 2026: 21Apr 2026: 15May 2026: 14Jun 2026: 32Jul 2026: 42Aug 2026: 109Sep 2026: 119Oct 2026: 44509 in 12 months
Clinical Journal of the American Society of Nephrology

Lower heart-health scores linked to end-stage kidney disease

Each 10-point lower heart-health score was linked to a hazard ratio—a measure of relative risk over time—of 1.47 for end-stage kidney disease.Each 10-point lower heart-health score was linked to a hazard ratio—a measure of relative risk over time—of 1.47 for end-stage kidney disease.

Cohort · 276,494 peopleEnd-stage kidney disease